119 related articles for article (PubMed ID: 35767882)
21. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
Zhang J; Zha W; Qian C; Ding A; Mao Z
Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
[TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
23. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
[TBL] [Abstract][Full Text] [Related]
24. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
25. Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan.
Bau DT; Wang HC; Liu CS; Chang CL; Chiang SY; Wang RF; Tsai CW; Lo YL; Hsiung CA; Lin CC; Huang CY
Chin J Physiol; 2009 Dec; 52(6):411-8. PubMed ID: 20337148
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
27. Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.
Xu B; Guo J; Chen M
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1105-1115. PubMed ID: 35748299
[TBL] [Abstract][Full Text] [Related]
28. Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.
Tanaka M; Kataoka H; Yano S; Ohi H; Kawamoto K; Shibahara T; Mizoshita T; Mori Y; Tanida S; Kamiya T; Joh T
BMC Cancer; 2013 May; 13():237. PubMed ID: 23672493
[TBL] [Abstract][Full Text] [Related]
29. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
[TBL] [Abstract][Full Text] [Related]
30. Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.
Izumchenko E; Saydi J; Brown KD
DNA Repair (Amst); 2012 Dec; 11(12):951-64. PubMed ID: 23062884
[TBL] [Abstract][Full Text] [Related]
31. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
Lu C; Shan Z; Li C; Yang L
Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
[TBL] [Abstract][Full Text] [Related]
32. Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway.
Al-Bahlani S; Burney IA; Al-Dhahli B; Al-Kharusi S; Al-Kharousi F; Al-Kalbani A; Ahmed I
BMC Pharmacol Toxicol; 2020 Sep; 21(1):64. PubMed ID: 32867831
[TBL] [Abstract][Full Text] [Related]
33. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
34. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
35. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
[TBL] [Abstract][Full Text] [Related]
36. Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B.
Wang J; Liu R; Mo H; Xiao X; Xu Q; Zhao W
Int J Biol Sci; 2021; 17(13):3331-3342. PubMed ID: 34512150
[TBL] [Abstract][Full Text] [Related]
37. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.
Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J
Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1.
Sheng H; Chen X; Liu B; Li P; Cao W
Anticancer Agents Med Chem; 2016; 16(9):1085-92. PubMed ID: 27025656
[TBL] [Abstract][Full Text] [Related]
39. The effects and mechanism of α-mangostin on chemosensitivity of gastric cancer cells.
Li RR; Zeng DY
Kaohsiung J Med Sci; 2021 Aug; 37(8):709-717. PubMed ID: 34003591
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
